Cotinga Pharmaceuticals EBITDA
Что обозначает EBITDA в Cotinga Pharmaceuticals?
EBITDA Cotinga Pharmaceuticals, Inc. является -CAD$2.14
Какое определение для EBITDA?
EBITDA - это прибыль компании до вычета процентов, налогов, обесценивания и амортизации, а также является бухгалтерской мерой, рассчитанной с использованием чистой прибыли компании до вычета процентных расходов, налогов, обесценивания и амортизации в качестве показателя текущей операционной прибыли компании.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA компаний в Health Care сектор на TSXV по сравнению с Cotinga Pharmaceuticals
Что делает Cotinga Pharmaceuticals?
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
Компании с ebitda похож на Cotinga Pharmaceuticals
- One Heritage PLC имеет EBITDA из -£2.16
- Saturn Metals имеет EBITDA из -AUD$2.16
- Stratabound Minerals имеет EBITDA из -CAD$2.15
- Structural Monitoring Systems Plc имеет EBITDA из -AUD$2.15
- Felix Gold имеет EBITDA из -$2.15
- Aurex имеет EBITDA из -CAD$2.14
- Cotinga Pharmaceuticals имеет EBITDA из -CAD$2.14
- Pharol, SGPS S.A имеет EBITDA из -€2.14
- Pharol, SGPS S.A имеет EBITDA из -€2.14
- NTM Gold имеет EBITDA из -AUD$2.14
- Kintavar Exploration имеет EBITDA из -CAD$2.14
- Banyan Gold имеет EBITDA из -CAD$2.14
- Banyan Gold имеет EBITDA из -CAD$2.14